Compumedics Limited (AU:CMP) has released an update.
Compumedics Limited bolsters its U.S. presence with the appointment of Craig Gallivan as National Vice President of Sales for its Home Sleep Testing (HST) segment, following FDA approval of their Somfit HST product. The company aims to tap into the lucrative sleep tech devices market, which is estimated to potentially generate up to $100 million annually in SaaS revenues. Gallivan’s proven track record in sales and CRM at Zoll Itamar, combined with Somfit’s unique diagnostic capabilities, positions Compumedics to capture significant market share in the U.S. home sleep testing industry.
For further insights into AU:CMP stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
